Significant differences were seen in the incidence of seizures, status epilepticus, visual disturbance, speech disorder, cognitive disorder/memory loss, psycho-behavioral abnormalities, involuntary movements, sleep disorders, and urinary retention between the MOG-AD and anti-NMDAR encephalitis groups (p < 0.05). The gene discussed is MOG; the disease is Alzheimer disease.